Table 1. The relationship of NCOA5 expression with CRC clinicopathological features (Pearson's χ2 test).
| Variables | Total | NCOA5 | P | |
|---|---|---|---|---|
| n=70 | Lown=15(21.4%) | Highn=55(78.6%) | ||
| Gender | 0.552 | |||
| Male | 42(60.0%) | 10 | 32 | |
| Female | 28(40.0%) | 5 | 23 | |
| Age (year) | 0.667 | |||
| < 65 | 34(48.6%) | 8 | 26 | |
| ≥ 65 | 36(51.4%) | 7 | 29 | |
| Length of tumor (cm) | < 0.001 | |||
| < 4 | 25(35.7%) | 12 | 13 | |
| ≥ 4 | 45(64.3%) | 3 | 41 | |
| Differentiation | 0.145 | |||
| Well | 7(10.0%) | 3 | 4 | |
| Moderate/Poor | 63(90.0%) | 12 | 51 | |
| Tumor location | 0.506 | |||
| Colon | 47(67.1%) | 9 | 38 | |
| Rectum | 23(32.9%) | 6 | 17 | |
| Depth of infiltrations | 0.276 | |||
| T1/T2/T3 | 16(22.9%) | 5 | 11 | |
| T4 | 54(77.1%) | 10 | 44 | |
| Regional Lymph nodes | 0.005 | |||
| N0 | 38(54.3%) | 13 | 25 | |
| N1/N2/N3 | 32(45.7%) | 2 | 30 | |
| Stage | 0.018 | |||
| I/II | 37(52.9%) | 12 | 25 | |
| III/IV | 33(47.1%) | 3 | 30 | |